UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients

Journal of the American Academy of Dermatology, 2016-01, Vol.74 (1), p.59-67

2016

Volltextzugriff (PDF)

Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: A case series of 34 patients

Journal of the American Academy of Dermatology, 2014-12, Vol.71 (6), p.1117-1126

2014

Volltextzugriff (PDF)

Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata

Journal of the American Academy of Dermatology, 2009-10, Vol.61 (4), p.592.e1-592.e9

2009

Volltextzugriff (PDF)

Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis

Journal of clinical oncology, 2015-11, Vol.33 (32), p.3759-3765

2015

Volltextzugriff (PDF)

Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sezary Syndrome from 1982 to 2009

Clinical cancer research, 2012-09, Vol.18 (18), p.5051-5060

2012

Volltextzugriff (PDF)

Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study

Journal of the American Academy of Dermatology, 2004-04, Vol.50 (4), p.600-607

2004

Volltextzugriff (PDF)

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Journal of clinical oncology, 2015-11, Vol.33 (32), p.3766-3773

2015

Volltextzugriff (PDF)

Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results

JAMA dermatology (Chicago, Ill.), 2017-12, Vol.153 (12), p.1302

2017

Volltextzugriff (PDF)

Pilot Study of Denileukin Diftitox Alternate Dosing Regimen in Patients With Cutaneous Peripheral T-Cell Lymphomas

Clinical lymphoma, myeloma and leukemia, 2012-06, Vol.12 (3), p.180-185

2012

Volltextzugriff (PDF)

Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides

Clinical lymphoma, myeloma and leukemia, 2016-01, Vol.16 (1), p.49-56

2016

Volltextzugriff (PDF)

Evaluation of Health Related Questionnaire Among Mycosis Fungoides and Lymphomatoid Papulosis

Blood, 2015-12, Vol.126 (23), p.5603-5603

2015

Volltextzugriff (PDF)

Lymphomatoid Papulosis: Assessing Treatment Response and Associated Lymphomas in a Study of 180 Patients

Blood, 2015-12, Vol.126 (23), p.1487-1487

2015

Volltextzugriff (PDF)

Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action

Journal of investigative dermatology, 2005-11, Vol.125 (5), p.1045-1052

2005

Volltextzugriff (PDF)

Optimizing denileukin diftitox (Ontak) therapy

Future oncology (London, England), 2008-08, Vol.4 (4), p.457-469

2008

Volltextzugriff (PDF)

Advanced-Stage Mycosis Fungoides and Sézary Syndrome: Survival and Response to Treatment

Clinical lymphoma, myeloma and leukemia, 2015-06, Vol.15 (6), p.e105-e112

2015

Volltextzugriff (PDF)

Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma

Expert review of clinical pharmacology, 2014-09, Vol.7 (5), p.591-597

2014

Volltextzugriff (PDF)

Overall survival in erythrodermic cutaneous T‐cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T‐cell lymphoma

International journal of dermatology, 2009-03, Vol.48 (3), p.243-252

2009

Volltextzugriff (PDF)

Pralatrexate Alone or in Combination With Bexarotene: Long-Term Tolerability in Relapsed/Refractory Mycosis Fungoides

Clinical lymphoma, myeloma and leukemia, 2014-08, Vol.14 (4), p.297-304

2014

Volltextzugriff (PDF)

Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome

Clinical lymphoma, myeloma and leukemia, 2015-05, Vol.15 (5), p.e83-e93

2015

Volltextzugriff (PDF)

Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma

Journal of cutaneous pathology, 2016-12, Vol.43 (12), p.1121-1130

2016

Volltextzugriff (PDF)

A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Blood advances, 2024-10, Vol.8 (19), p.5012-5021

2024

Volltextzugriff (PDF)

Clinical Features of Folliculotrophic Mycosis Fungoides

Blood, 2015-12, Vol.126 (23), p.1488-1488

2015

Volltextzugriff (PDF)

A Single Center Experience With Pralatrexate Alone Or In Combination With Bexarotene: Long Term Responses In Advanced Stage Relapsed/Refractory Cutaneous T-Cell Lymphoma

Blood, 2013-11, Vol.122 (21), p.5113-5113

2013

Volltextzugriff (PDF)

Prognostic Factors, Staging and Treatments in Advanced Stage Mycosis Fungoides and Sézary Syndrome

Blood, 2014-12, Vol.124 (21), p.1673-1673

2014

Volltextzugriff (PDF)

Primary Cutaneous Small to Medium-Size CD4+ Pleomorphic T-Cell Lymphoma: 48 Patients from Two Independent Centers and Revaluation of Clinico-Histological Criteria for Differential Diagnosis from Other CTCL

Blood, 2014-12, Vol.124 (21), p.2986-2986

2014

Volltextzugriff (PDF)

1 – 25 von 64

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(58)

Publikationsform

Artikel
(63)
Berichte
(1)

Sprache

Englisch
(63)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients

Clinical presentation, immunopathology, and treatment of juvenile-onset mycosis fungoides: A case series of 34 patients

Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata

Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis

Long-term Outcomes of 1,263 Patients with Mycosis Fungoides and Sezary Syndrome from 1982 to 2009

Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study

Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model

Brentuximab Vedotin for Patients With Refractory Lymphomatoid Papulosis: An Analysis of Phase 2 Results

Pilot Study of Denileukin Diftitox Alternate Dosing Regimen in Patients With Cutaneous Peripheral T-Cell Lymphomas

Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides

Evaluation of Health Related Questionnaire Among Mycosis Fungoides and Lymphomatoid Papulosis

Lymphomatoid Papulosis: Assessing Treatment Response and Associated Lymphomas in a Study of 180 Patients

Selective Induction of Apoptosis by Histone Deacetylase Inhibitor SAHA in Cutaneous T-Cell Lymphoma Cells: Relevance to Mechanism of Therapeutic Action

Optimizing denileukin diftitox (Ontak) therapy

Advanced-Stage Mycosis Fungoides and Sézary Syndrome: Survival and Response to Treatment

Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma

Overall survival in erythrodermic cutaneous T‐cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T‐cell lymphoma

Pralatrexate Alone or in Combination With Bexarotene: Long-Term Tolerability in Relapsed/Refractory Mycosis Fungoides

Long-Term Complete Responses to Combination Therapies and Allogeneic Stem Cell Transplants in Patients With Sézary Syndrome

Clinicopathological and molecular study of primary cutaneous CD4+ small/medium-sized pleomorphic T-cell lymphoma

A.R.R.O.W.2: once- vs twice-weekly carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma

Clinical Features of Folliculotrophic Mycosis Fungoides

A Single Center Experience With Pralatrexate Alone Or In Combination With Bexarotene: Long Term Responses In Advanced Stage Relapsed/Refractory Cutaneous T-Cell Lymphoma

Prognostic Factors, Staging and Treatments in Advanced Stage Mycosis Fungoides and Sézary Syndrome

Primary Cutaneous Small to Medium-Size CD4+ Pleomorphic T-Cell Lymphoma: 48 Patients from Two Independent Centers and Revaluation of Clinico-Histological Criteria for Differential Diagnosis from Other CTCL

Suchergebnisse filtern